PhD (1996) in Pharmacy (Microbiology), Universidade de Lisboa
Full Professor, Microbiology and Molecular Biology, Instituto Superior de Ciências da Saúde Egas Moniz
Group Leader, HIV Evolution, Epidemiology and Prevention at iMed.ULisboa
Faculdade de Farmácia, Universidade de Lisboa — Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal
Taveira leads a group investigating the epidemiology, transmission dynamics, diversity and drug resistance of HIV, HCV, Yellow Fever virus and other viruses in Portugal, Angola, Mozambique and Cape Verde. The sequence data along with virus isolates and their genomic material is used in the production/validation of new diagnostic tests, implementation of better treatment regimens and development of new antiviral drugs as well as new vaccine and microbicide candidates. His group also performs the pre-clinical evaluation of new vaccine and microbicide candidates and new drugs for the treatment, prevention and cure of HIV infection.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390:1211-1259
Rocha C, Duarte J, Calado R, Marcelino JM, Borrego P, Palladino C, Tendeiro R, Fernandes S, Valadas E, Antunes F, Sousa AE, Taveira N. Potent and broadly neutralizing antibodies despite marked memory B cell depletion in chronic HIV-2 infection. AIDS 2017; 31:2431-2433
Romero-Severson EO, Bulla I, Hengartner N, Bártolo I, Abecasis A, Azevedo-Pereira JM, Taveira N, Leitner T. Donor-recipient identification in para- and poly-phyletic trees under alternative HIV-1 transmission hypotheses using approximate Bayesian computation. Genetics 2017; 207: 1089-1101
Borrego P, Gonçalves MF, Gomes P, Araújo L, Moranguinho I, Figueiredo IB, Barahona I, Rocha J, Mendonça C, Cruz MC, Barreto J, Taveira N. Assessment of the Cavidi ExaVir™ Load assay for monitoring plasma viral load in HIV-2 infected patients. J Clin Microbiol 2017; 55: 2367-2379
Kraemer MUG, Faria NR, Reiner RC, Golding N, Nikolay B, Johansson MA, Salje H, Faye O, Wint GRW, Niedrig M, Shearer FM, Hill SC, Thompson RN, Bisanzio D, Taveira N, Nax H, Pradelski BSR, Murphy NR, Bogoch II, Khan K, Brownstein JS, Tatem AJ, de Oliveira T, Smith DL, Sall A, Pybus OG, Hay SI, Cauchemez S. Spread of Yellow Fever Virus outbreak in Angola and the Democratic Republic Congo 2015-2016: a modelling study. Lancet Infect Dis. 2017; 17: 330-338.